Case: Impax Laboratories, Inc. Attorneys: Jeffrey P. Campisi
June 8, 2011 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Impax Laboratories Inc. (“Impax” or the “Company”) (Nasdaq: IPXL) for potential violations of the federal securities laws. Investors who purchased Company securities may be affected.
**** No further details, thus what kind of violations is unknown to us.
Rule of Thumb: Whenever IPXL starts climbing, "Frankpostin" (or "Prejudiced Phil" as his closest asssociates may know him)comes up with these 'deep left field' comments and criticisms about the company. While IPXL isn't perfect anyone who follows Pharma knows that this kind of news is both old and common place! (Just look at litigation against major Pharma over the past five years!!) Get a life Frank, and stop trying to drive down and bash IPXL.
Since you are living in the SF Bay-area, perhaps, you should drive to Hayward and tell Larry, personally, to "stop trying to drive down and bash IPXL." It's definitely Larry's responsibility of defaulting FDA's and SEC's rules.